Sutee Yoksan

Sutee Yoksan (Thai: สุธี ยกส้าน, born 1949) is a Thai research physician, known for his work on dengue vaccines, as well as those against other mosquito-borne diseases. He is an emeritus professor at Mahidol University, where he headed its Center for Vaccine Development from 1991 until his retirement in 2014 and now holds an advisory position.[1] His work forms the basis of Takeda's Qdenga vaccine, which was approved in the European Union in 2022.[2] He received the Dushdi Mala Medal, Pin of Arts and Science in 2020.[3]

References

Karnjanatawe, Karnjana (30 May 2022). "Dengue vaccine pioneer in search of salvation". Bangkok Post. Retrieved 12 May 2023.
"Beyond the Journal: The science of communication The story behind the new dengue vaccine". Asia Research News. 17 August 2022. Retrieved 12 May 2023.
"เหรียญดุษฎีมาลา เข็มศิลปวิทยา สาขาวิทยาศาสตร์ ประจำปี 2562" (in Thai and English). Institute of Molecular Biosciences, Mahidol University. Retrieved 12 May 2023.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Karnjanatawe, Karnjana (30 May 2022). "Dengue vaccine pioneer in search of salvation". Bangkok Post. Retrieved 12 May 2023.

[2] "Beyond the Journal: The science of communication The story behind the new dengue vaccine". Asia Research News. 17 August 2022. Retrieved 12 May 2023.

[3] "เหรียญดุษฎีมาลา เข็มศิลปวิทยา สาขาวิทยาศาสตร์ ประจำปี 2562" (in Thai and English). Institute of Molecular Biosciences, Mahidol University. Retrieved 12 May 2023.